The economic and human costs of asthma in Scotland

Neville, Ron; Hoskins, Gaylor; Smith, Barbara; McCowan, Colin

doi:10.1038/pcrj.2003.64

Cited by 8 publications

(12 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The study reported that the urgent care costs were higher than maintenance costs in the participating areas: Singapore, Hong Kong, Malaysia and China, representing 62% of the total costs [ 31 ]. In contrast costs of maintenance therapy were reported to be more important in adults and children, respectively accounting for 67% of total health services in one study [ 62 ] and 55% and 73% of the total direct costs of treatment in another study [ 63 ]. None of the two latter studies were of high quality and thus, may not be a true reflection of the overall economic impact of asthma.…”

Section: Resultsmentioning

confidence: 99%

Economic burden of asthma: a systematic review

et al. 2009

View full text Add to dashboard Cite

BackgroundAsthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma.MethodsWe performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.ResultsSixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity.ConclusionDespite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.

show abstract

Section: Resultsmentioning

confidence: 99%

Economic burden of asthma: a systematic review

et al. 2009

View full text Add to dashboard Cite

show abstract

“…Some studies have found higher costs in private versus public or non-profit hospitals. However, the difference is only around 20 to 30% of the cost [36–39]. …”

Section: Introductionmentioning

confidence: 99%

Asthma costs and social impact

Nunes¹,

Pereira

Morais‐Almeida

2017

asthma res and pract

616

394

View full text Add to dashboard Cite

In recent decades, both asthma prevalence and incidence have been increasing worldwide, not only due to the genetic background, but mainly because of the effect of a wide number of environmental and lifestyle risk factors.In many countries noncommunicable diseases, like asthma, are not yet considered a healthcare priority. This review will analyze and discuss disparities in asthma management in several countries and regions, such as access to healthcare human resources and medications, due to limited financial capacity to develop strategies to control and prevent this chronic disease.This review tries to explore the social and economic burden of asthma impact on society. Although asthma is generally accepted as a costly illness, the total costs to society (direct, indirect and intangible asthma costs) are difficult to estimate, mainly due to different disease definitions and characterizations but also to the use of different methodologies to assess the asthma socio-economic impact in different societies.The asthma costs are very variables from country to country, however we can estimate that a mean cost per patient per year, including all asthmatics (intermittent, mild, moderate and severe asthma) in Europe is $USD 1,900, which seems lower than USA, estimated mean $USD 3,100.

show abstract

“…The NHS costs of asthma in the UK have been estimated at around £750 million per annum (2004 prices)2 3 while estimates from other countries vary, largely because of different approaches to costing 4–9. Costs increase with asthma severity,10–12 those for mild asthma being about half those for moderate asthma, and severe asthma costing about 2.5 times more than moderate asthma.…”

Section: Introductionmentioning

confidence: 99%

Costs of occupational asthma in the UK

Ayres

Boyd

Cowie

et al. 2010

Thorax

View full text Add to dashboard Cite

Objectives To estimate the social costs of occupational asthma in the UK. Methods A desk-top approach using cost-of-illness methodology was employed, defining direct and indirect lifetime costs for six scenarios: a male and a female worker each exposed to isocyanates, latex and biocides (eg, glutaraldehyde) or flour. The numbers of new cases annually in each industry were estimated from Survey of Work-related and Occupational Respiratory Disease (SWORD) data. The main outcome measure was the current value total working lifetime costs of new cases annually for each scenario. Results Assuming 209 new cases of occupational asthma in the six scenarios in the year 2003, the present value total lifetime costs were estimated to be £25.3e27.3 million (2004 prices). Grossing up for all estimated cases of occupational asthma in the UK in 2003, this came to £70e100 million. About 49% of these costs were borne by the individual, 48% by the state and 3% by the employer. Conclusions The cost to society of occupational asthma in the UK is high. Given that the number of newly diagnosed cases is likely to be underestimated by at least one-third, these costs may be as large as £95e135 million. Each year a new stream of lifetime costs will be added as a newly diagnosed cohort is identified. Approaches to reduce the burden of occupational asthma have a strong economic justification. However, the economic burden falls on the state and the individual, not on the employer.

show abstract

The economic and human costs of asthma in Scotland

Cited by 8 publications

References 4 publications

Economic burden of asthma: a systematic review

Economic burden of asthma: a systematic review

Asthma costs and social impact

Costs of occupational asthma in the UK

Contact Info

Product

Resources

About